Search research articles
Contact Us
Filters
Showing results (21-30 of 148) with videos related to
Page
of 15
Sort By:
The Journal of Physical Chemistry Letters
|
November 5, 2024
Explicit Configurational Entropy of Mixing in Molecular Dynamics Simulations
T Hanke, A L Upterworth, D Sebastiani
European Journal of Immunology
|
August 14, 2001
Vav-1 regulates NK T cell development and NK cell cytotoxicity
G Chan, T Hanke, K D Fischer
European Journal of Immunology
|
December 18, 2001
MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model
T Hanke, H Takizawa, D H Raulet
Biological Chemistry
|
December 18, 2012
Plant cell microcompartments: a redox-signaling perspective
Sabine Zachgo, Guy T Hanke, Renate Scheibe
European Journal of Immunology
|
October 1, 1996
Identification and cellular distribution of the rat interleukin-2 receptor beta chain: induction of the IL-2R alpha- beta+ phenotype by major histocompatibility complex class I recognition during T cell development in vivo and by T cell receptor stimulation of CD4+8+ immature thymocytes in vitro
J H Park, T Hanke, T Hünig
Der Orthopade
|
March 23, 2011
[Resorbable bone substitution materials: An overview of commercially available materials and new approaches in the field of composites]
S Heinemann, M Gelinsky, H Worch, et al.
AIDS (London, England)
|
July 1, 1993
Sequence homology between HIV-1 gp120 and the apoptosis mediating protein Fas
P W Szawlowski, T Hanke, R E Randall
European Journal of Immunology
|
January 1, 1997
CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: evidence for functionally distinct forms of CD28
M Tacke, G Hanke, T Hanke, et al.
Biomedica Biochimica Acta
|
January 1, 1983
Mechanism studies of enzymatically formed tolidine blue and determination of peroxidatic activities
P Mohr, T Hanke, W Kuhn, et al.
Annals of the Rheumatic Diseases
|
October 22, 2005
Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases
N Beyersdorf, T Hanke, T Kerkau, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 148) with videos related to
Sort By:
Page
of 15
The Journal of Physical Chemistry Letters
|
November 5, 2024
Explicit Configurational Entropy of Mixing in Molecular Dynamics Simulations
T Hanke, A L Upterworth, D Sebastiani
European Journal of Immunology
|
August 14, 2001
Vav-1 regulates NK T cell development and NK cell cytotoxicity
G Chan, T Hanke, K D Fischer
European Journal of Immunology
|
December 18, 2001
MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model
T Hanke, H Takizawa, D H Raulet
Biological Chemistry
|
December 18, 2012
Plant cell microcompartments: a redox-signaling perspective
Sabine Zachgo, Guy T Hanke, Renate Scheibe
European Journal of Immunology
|
October 1, 1996
Identification and cellular distribution of the rat interleukin-2 receptor beta chain: induction of the IL-2R alpha- beta+ phenotype by major histocompatibility complex class I recognition during T cell development in vivo and by T cell receptor stimulation of CD4+8+ immature thymocytes in vitro
J H Park, T Hanke, T Hünig
Der Orthopade
|
March 23, 2011
[Resorbable bone substitution materials: An overview of commercially available materials and new approaches in the field of composites]
S Heinemann, M Gelinsky, H Worch, et al.
AIDS (London, England)
|
July 1, 1993
Sequence homology between HIV-1 gp120 and the apoptosis mediating protein Fas
P W Szawlowski, T Hanke, R E Randall
European Journal of Immunology
|
January 1, 1997
CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: evidence for functionally distinct forms of CD28
M Tacke, G Hanke, T Hanke, et al.
Biomedica Biochimica Acta
|
January 1, 1983
Mechanism studies of enzymatically formed tolidine blue and determination of peroxidatic activities
P Mohr, T Hanke, W Kuhn, et al.
Annals of the Rheumatic Diseases
|
October 22, 2005
Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases
N Beyersdorf, T Hanke, T Kerkau, et al.
Page
of 15